| BCL-2 protein family: attractive targets for cancer therapy D Kaloni, ST Diepstraten, A Strasser, GL Kelly Apoptosis 28 (1), 20-38, 2023 | 261 | 2023 |
| Pharmaceutical effluent: a critical link in the interconnected ecosystem promoting antimicrobial resistance A Kotwani, J Joshi, D Kaloni Environmental Science and Pollution Research 28 (25), 32111-32124, 2021 | 99 | 2021 |
| Knowledge and behavior of consumers towards the non-prescription purchase of antibiotics: An insight from a qualitative study from New Delhi, India A Kotwani, J Joshi, AS Lamkang, A Sharma, D Kaloni Pharmacy Practice (Granada) 19 (1), 2021 | 39 | 2021 |
| Loss-of-function but not gain-of-function properties of mutant TP53 are critical for the proliferation, survival, and metastasis of a broad range of cancer cells Z Wang, M Burigotto, S Ghetti, F Vaillant, T Tan, BD Capaldo, M Palmieri, ... Cancer Discovery 14 (2), 362-379, 2024 | 37 | 2024 |
| In silico studies on the phytochemical components of Murraya koenigii targeting TNF-α in rheumatoid arthritis D Kaloni, D Chakraborty, A Tiwari, S Biswas Journal of Herbal Medicine 24, 100396, 2020 | 30 | 2020 |
| Current research and perspectives on microalgae-derived biodiesel K Singh, D Kaloni, S Gaur, S Kushwaha, G Mathur Biofuels, 2020 | 25 | 2020 |
| Loss-of-Function but Not Gain-of-Function Properties of Mutant TP53 Are Critical for the Proliferation, Survival, and Metastasis of a Broad Range of Cancer Cells. Cancer Discov … Z Wang, M Burigotto, S Ghetti, F Vaillant, T Tan, BD Capaldo, M Palmieri, ... CD-23-0402, 2024 | 7 | 2024 |
| Genome-wide CRISPR screening identifies a role for ARRDC3 in TRP53-mediated responses JE La Marca, BJ Aubrey, B Yang, C Chang, Z Wang, A Kueh, L Tai, ... Cell Death & Differentiation 31 (2), 150-158, 2024 | 4 | 2024 |
| BH3 mimetics and TKI combined therapy for Chronic Myeloid Leukemia G Brumatti, D Kaloni, FA Castro, GP Amarante-Mendes Biochemical Journal 480 (2), 161-176, 2023 | 3 | 2023 |
| Aloe vera as an antagonist for TNF-alpha: In-silico study D Kaloni, A Tiwari, S Biswas Pharmacology 4 (10), 2019 | 2 | 2019 |
| Mouse models to investigate in situ cell fate decisions induced by p53 E Lieschke, AF Thomas, A Kueh, GK Atkin-Smith, PL Baldoni, ... The EMBO journal 43 (19), 4406-4436, 2024 | 1 | 2024 |
| Essential oils: An update on their biosynthesis and genetic strategies to overcome the production challenges K Singh, D Kaloni, K Sehgal, S Pan, IP Sarethy Plant-derived bioactives: production, properties and therapeutic …, 2020 | 1 | 2020 |
| Genome-wide CRISPR screening identifies a role for ARRDC3 in TRP53-mediated responses M Herold, J La Marca, B Aubrey, B Yang, C Chang, Z Wang, A Kueh, L Tai, ... | | 2023 |
| Genome-wide in vivo CRISPR screens identify GATOR1 as a potent tumor suppressor and its loss sensitizes MYC-driven lymphomas to mTOR inhibition MA Potts, S Mizutani, Y Deng, S Vaidyanathan, KE Ting, G Giner, ... bioRxiv, 2022.02. 16.480657, 2022 | | 2022 |
| Rheumatoid Arthritis: Risks & Management D Kaloni, D Chakraborty, A Tiwari, S Biswas | | 2019 |
